HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bob Siegerink Selected Research

Bob Siegerink Research Topics

Disease

17Ischemic Stroke
10/2022 - 11/2009
16Stroke (Strokes)
10/2022 - 10/2015
7Thrombosis (Thrombus)
01/2018 - 11/2009
6Myocardial Infarction
01/2017 - 08/2009
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2013
3Venous Thrombosis (Deep-Vein Thrombosis)
07/2017 - 07/2013
2Cerebral Hemorrhage
10/2020 - 04/2016
1Brain Ischemia (Cerebral Ischemia)
01/2021
1Migraine Disorders (Migraine)
01/2021
1Critical Illness (Critically Ill)
10/2020
1Sepsis (Septicemia)
10/2020
1Pneumonia (Pneumonitis)
10/2020
1Atrial Fibrillation
01/2020
1Dementia (Dementias)
01/2019
1Out-of-Hospital Cardiac Arrest
01/2018
1Perinatal Death
12/2017
1Embolism (Embolus)
06/2017
1Peripheral Arterial Occlusive Disease 1
01/2017
1Stillbirth
01/2016
1Edema (Dropsy)
01/2016
1Spontaneous Abortion (Miscarriage)
01/2016
1Leukocytosis (Pleocytosis)
01/2016
1Thrombophilia
01/2015
1Obesity
07/2013
1Coronary Disease (Coronary Heart Disease)
03/2013
1ST Elevation Myocardial Infarction
05/2011
1Inflammation (Inflammations)
05/2011
1Hypertension (High Blood Pressure)
11/2009
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2009

Drug/Important Bio-Agent (IBA)

4AntibodiesIBA
10/2022 - 11/2009
4Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2017
4Oral ContraceptivesIBA
01/2016 - 11/2009
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2022 - 11/2019
3Troponin T (Troponin T1)IBA
01/2021 - 01/2019
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2020 - 04/2016
3TroponinIBA
01/2020 - 01/2019
2Immunoglobulin A (IgA)IBA
10/2022 - 11/2019
2Immunoglobulin G (IgG)IBA
10/2022 - 11/2019
2Immunoglobulin M (IgM)IBA
10/2022 - 11/2019
2fibrin fragment D (D-dimer)IBA
01/2021 - 10/2016
2Hemostatics (Antihemorrhagics)IBA
01/2021 - 01/2017
2Blood Coagulation Factors (Coagulation Factor)IBA
12/2020 - 01/2015
2N-Methylaspartate (NMDA)IBA
01/2020 - 11/2019
2Antiphospholipid AntibodiesIBA
01/2016 - 11/2009
1Triglycerides (Triacylglycerol)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1SugarsIBA
01/2022
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2021
1Fibrinogen (Factor I)FDA Link
01/2021
1Plasminogen Activator Inhibitor 1IBA
01/2021
1SmokeIBA
01/2021
1Factor XII (Hageman Factor)IBA
12/2020
1trans-crotonin (CTN)IBA
01/2020
1Neuroprotective AgentsIBA
11/2019
1Protein CIBA
01/2018
1insulin receptor-related receptor (IRR)IBA
12/2017
1RNA (Ribonucleic Acid)IBA
06/2017
1Indicators and Reagents (Reagents)IBA
02/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Lipoprotein(a)IBA
10/2015
1Lipoproteins (Lipoprotein)IBA
10/2015
1Biological ProductsIBA
07/2013
1symmetric dimethylarginineIBA
03/2013
1AntigensIBA
02/2012
1Sirolimus (Rapamycin)FDA Link
05/2011
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2009
1Factor XIII (Coagulation Factor XIII)IBA
08/2009

Therapy/Procedure

3Thrombectomy
01/2021 - 01/2020
1Time-to-Treatment
01/2021
1Critical Care (Surgical Intensive Care)
10/2020
1Defibrillators (Defibrillator)
01/2018
1Stents
05/2011